Compile Data Set for Download or QSAR

Found 2 hits Enz. Inhib. hit(s) with Target = 'Glucocorticoid receptor' and Ligand = 'BDBM141384'   

Target/Host (Institution)	Ligand	Target/Host Links	Ligand Links	Trg + Lig Links	Ki nM	ΔG° kJ/mole	IC50 nM	Kd nM	EC50/IC50 nM	koff s-1	kon M-1s-1	pH	Temp °C
Glucocorticoid receptor (Homo sapiens (Human))	BDBM141384 (US8916600, 18 | US9738632, Example 18) Show SMILES C[C@H](NC(=O)C(C)(F)F)[C@H](Oc1ccc2n(ncc2c1)-c1cccc(c1)C(=O)N[C@H]1CCC[C@@H]1O)c1ccc2COCOc2c1 |r| Show InChI InChI=1S/C33H34F2N4O6/c1-19(37-32(42)33(2,34)35)30(20-9-10-22-17-43-18-44-29(22)15-20)45-25-11-12-27-23(14-25)16-36-39(27)24-6-3-5-21(13-24)31(41)38-26-7-4-8-28(26)40/h3,5-6,9-16,19,26,28,30,40H,4,7-8,17-18H2,1-2H3,(H,37,42)(H,38,41)/t19-,26-,28-,30-/m0/s1	PDB KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem Similars	US Patent	n/a	n/a	3.44	n/a	n/a	n/a	n/a	n/a	n/a
AstraZeneca AB; Bayer Pharma Aktiengesellschaft US Patent					Assay Description In the GR radioligand binding assay, test compounds were serially diluted in semi-log steps (10 concentrations) with a final concentration of 10 _...				US Patent US9738632 (2017) BindingDB Entry DOI: 10.7270/Q2057J12
					More data for this Ligand-Target Pair
Glucocorticoid receptor (Homo sapiens (Human))	BDBM141384 (US8916600, 18 | US9738632, Example 18) Show SMILES C[C@H](NC(=O)C(C)(F)F)[C@H](Oc1ccc2n(ncc2c1)-c1cccc(c1)C(=O)N[C@H]1CCC[C@@H]1O)c1ccc2COCOc2c1 |r| Show InChI InChI=1S/C33H34F2N4O6/c1-19(37-32(42)33(2,34)35)30(20-9-10-22-17-43-18-44-29(22)15-20)45-25-11-12-27-23(14-25)16-36-39(27)24-6-3-5-21(13-24)31(41)38-26-7-4-8-28(26)40/h3,5-6,9-16,19,26,28,30,40H,4,7-8,17-18H2,1-2H3,(H,37,42)(H,38,41)/t19-,26-,28-,30-/m0/s1	PDB KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem Similars	US Patent	n/a	n/a	3.44	n/a	n/a	n/a	n/a	7.4	25
Astrazeneca AB; Bayer Pharma Aktiengesellschaft US Patent					Assay Description In the GR radioligand binding assay, test compounds were serially diluted in semi-log steps (10 concentrations) with a final concentration of 10 uM. ...				US Patent US8916600 (2014) BindingDB Entry DOI: 10.7270/Q2WQ02HG
					More data for this Ligand-Target Pair